Sarasin & Partners LLP, a registered investment adviser, initiated a new position in Thermo Fisher Scientific Inc. (NYSE:TMO) during Q4 2025, according to its most recent 13F…
Sarasin & Partners LLP, a registered investment adviser, initiated a new position in Thermo Fisher Scientific Inc. (NYSE:TMO) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 264,529 shares of the Healthcare company, valued at approximately $153,281,334 as of the filing date.
Thermo Fisher Scientific Inc.'s stock currently trades at $622.43 with a market capitalization of $219,392,514,369.
Current market data
NYSE · TMO
$665.30
Up: +$11.23 · +1.69%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
institutional ·
institutional ·
institutional ·
insider ·
